These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26905985)

  • 1. Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.
    Mukerji S; Shahpuri B; Clayton-Smith B; Smith N; Armstrong P; Hardy M; Marchant G; Marsh E
    N Z Med J; 2015 Nov; 128(1425):34-42. PubMed ID: 26905985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic counts on mortality, New Zealand Cancer Registry and census data: 2006-2011.
    Boyd M; Blakely T; Atkinson J
    N Z Med J; 2016 Jan; 129(1429):22-39. PubMed ID: 26914296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial.
    Edwards L; Shirtcliffe P; Wadsworth K; Healy B; Jefferies S; Weatherall M; Beasley R;
    Thorax; 2013 Apr; 68(4):338-43. PubMed ID: 23299960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma.
    Singh AK; Gaur S; Kumar R
    Iran J Allergy Asthma Immunol; 2008 Dec; 7(4):221-9. PubMed ID: 19052352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: a randomized trial.
    Nouira S; Bouida W; Grissa MH; Beltaief K; Trimech MN; Boubaker H; Marghli S; Letaief M; Boukef R
    Am J Ther; 2014; 21(3):152-8. PubMed ID: 22407196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department.
    Gallegos-Solórzano MC; Pérez-Padilla R; Hernández-Zenteno RJ
    Pulm Pharmacol Ther; 2010 Oct; 23(5):432-7. PubMed ID: 20416389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children.
    Powell CV; Kolamunnage-Dona R; Lowe J; Boland A; Petrou S; Doull I; Hood K; Williamson PR;
    Health Technol Assess; 2013 Oct; 17(45):v-vi, 1-216. PubMed ID: 24144222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalization: a randomized placebo-controlled trial].
    Abreu González J; Hernández García C; Abreu González P; Martín García C; Jiménez A
    Arch Bronconeumol; 2006 Aug; 42(8):384-7. PubMed ID: 16948990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
    Dal Negro RW; Visconti M; Turco P
    Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.
    Vogelmeier CF; Bateman ED; Pallante J; Alagappan VK; D'Andrea P; Chen H; Banerji D
    Lancet Respir Med; 2013 Mar; 1(1):51-60. PubMed ID: 24321804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator responsiveness in patients with COPD.
    Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S
    Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
    Martinez FJ; Calverley PM; Goehring UM; Brose M; Fabbri LM; Rabe KF
    Lancet; 2015 Mar; 385(9971):857-66. PubMed ID: 25684586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease.
    Skorodin MS; Tenholder MF; Yetter B; Owen KA; Waller RF; Khandelwahl S; Maki K; Rohail T; D'Alfonso N
    Arch Intern Med; 1995 Mar; 155(5):496-500. PubMed ID: 7864705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
    Duffy N; Walker P; Diamantea F; Calverley PM; Davies L
    Thorax; 2005 Sep; 60(9):713-7. PubMed ID: 15939732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.